Circulating fibrocytes are increased in children and young adults with pulmonary hypertension

European Respiratory Journal

Volumn 39, Issue 1, 2012, Pages 104-111

  Yeager, M E ^a   Nguyen, C M ^a   Belchenko, D D ^a   Colvin, K L ^b   Takatsuki, S ^a   Ivy, D D ^b   Stenmark, K R ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Fluorescence activated cell sorting; Inflammation; Mononuclear phagocyte; Progenitor cells; Vascular remodelling

Indexed keywords

AMBRISENTAN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BOSENTAN; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CD45 ANTIGEN; ILOPROST; MONOCYTE CHEMOTACTIC PROTEIN 1; PROCOLLAGEN; PROSTACYCLIN; SILDENAFIL; STROMAL CELL DERIVED FACTOR 1; TADALAFIL; UNIPROST;

6 MINUTE WALK DISTANCE; ADOLESCENT; ADULT; AGE; ANTIGEN EXPRESSION; ARTICLE; BLOOD ANALYSIS; BONE MARROW; CELL COUNT; CELL SELECTION; CELL SUBPOPULATION; CHILD; CIRCULATING FIBROCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FUNCTIONAL ASSESSMENT; HEART ARRHYTHMIA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOPHENOTYPING; LUNG ARTERY PRESSURE; MALE; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; TREATMENT DURATION;

ADOLESCENT; ADULT; ANTIGENS, CD45; CASE-CONTROL STUDIES; CELL SEPARATION; CHEMOKINE CCL2; CHEMOKINE CXCL12; CHILD; FEMALE; FIBROBLASTS; FLOW CYTOMETRY; HUMANS; HYPERTENSION, PULMONARY; INFLAMMATION; MALE; MESODERM; PHAGOCYTES; STEM CELLS; YOUNG ADULT;

EID: 84855404604     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00072311     Document Type: Article

References (30)

1. Humbert M. Update in pulmonary hypertension 2008. Am J Respir Crit Care Med 2009; 179: 650-656.
2. Barst RJ, Ertel SI, Beghetti M, et al. Pulmonary arterial hypertension: a comparison between children and adults. Eur Respir J 2011; 37: 1-13.
3. Morrell NW, Adnot S, Archer SL, et al. Cellular andmolecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54: S20-S31.
4. Toshner M, Voswinckel R, Southwood M, et al. Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension. Am J Respir Crit Care Med 2009; 180: 780-787.
5. Junhui Z, Xingxiang W, Guosheng F, et al. Reduced number and activity of circulating endothelial progenitor cells in patients with idiopathic pulmonary arterial hypertension. Respir Med 2008; 102: 1073-1079.
6. Smadja DM, Mauge L, Gaussem P, et al. Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension. Angiogenesis 2010; 14: 17-27.
7. Asosingh K, Aldred MA, Vasanji A, et al. Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension. Am J Pathol 2008; 172: 615-627. (Pubitemid 351354535)
8. Diller GP, van Eijl S, Okonko DO, et al. Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. Circulation 2008; 117: 3020-3030.
9. Hall S, Brogan P, Haworth SG, et al. Contribution of inflammation to the pathology of idiopathic pulmonary arterial hypertension in children. Thorax 2009; 64: 778-783.
10. Gambaryan N, Perros F, Montani D, et al. Targeting of c-kit+ hematopoietic progenitor cells prevents hypoxic pulmonary hypertension. Eur Respir J 2011; 37: 1392-1399.
11. Davie NJ, Crossno JT Jr, Frid MG, et al. Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells. Am J Physiol Lung Cell Mol Physiol 2004; 286: L668-L678. (Pubitemid 38365049)
12. Stenmark KR, Frid MG, Yeager ME. Fibrocytes: potential new therapeutic targets for pulmonary hypertension? Eur Respir J 2010; 36: 1232-1235.
13. Frid MG, Brunetti JA, Burke DL, et al. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol 2006; 168: 659-669. (Pubitemid 43271163)
14. Sun L, Louie MC, Vannella KM, et al. Newconcepts of IL-10 induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis. Am J Physiol Lung Cell Mol Physiol 2010; 300: L341-L353.
15. Keeley EC, Mehrad B, Strieter RM. Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis. Int J Biochem Cell Biol 2010; 42: 535-542.
16. Moeller A, Gilpin SE, Ask K, et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009; 179: 588-594.
17. Lama VN, Phan SH. The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond. Proc Am Thorac Soc 2006; 3: 373-376. (Pubitemid 43845415)
18. Nikam VS, Schermuly RT, Dumitrascu R, et al. Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension. Eur Respir J 2010; 36: 1302-1314.
19. Mathai SK, Gulati M, Peng X, et al. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest 2010; 90: 812-823.
20. Frid MG, Li M, Gnanasekharan M, et al. Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. Am J Physiol Lung Cell Mol Physiol 2009; 297: L1059-L1072.
21. Bucala R, Spiegel LA, Chesney J, et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994; 1: 71-81.
22. Bellini A, Mattoli S. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest 2007; 87: 858-870. (Pubitemid 47267815)
23. Maharjan AS, Pilling D, Gomer RH. Toll-like receptor 2 agonists inhibit human fibrocyte differentiation. Fibrogenesis Tissue Repair 2010; 3: 23.
24. Wang CH, Huang CD, Lin HC, et al. Increased circulating fibrocytes in asthma with chronic airflow obstruction. Am J Respir Crit Care Med 2008; 178: 583-591.
25. Hong KM, Belperio JA, Keane MP, et al. Differentiation of human circulating fibrocytes as mediated by transforming growth factor-βand peroxisome proliferator-activated receptor gamma. J Biol Chem 2007; 282: 22910-22920. (Pubitemid 47267358)
26. Song JS, Kang CM, Kang HH, et al. Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis. Exp Mol Med 2010; 42: 465-472.
27. Stenmark KR, Davie NJ, Reeves JT, et al. Hypoxia, leukocytes, and the pulmonary circulation. J Appl Physiol 2005; 98: 715-721. (Pubitemid 40129987)
28. Galligan CL, Siminovitch KA, Keystone EC, et al. Fibrocyte activation in rheumatoid arthritis. Rheumatology (Oxford) 2010; 49: 640-651.
29. Pilling D, Fan T, Huang D, et al. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One 2009; 4: e7475.
30. Pilling D, Roife D, Wang M, et al. Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. J Immunol 2007; 179: 4035-4044.